Farmed Whiteleg Shrimps Market Size
The Farmed Whiteleg Shrimps Market was valued at USD 31,851.22 million in 2024 and is expected to reach USD 33,794.14 million in 2025, growing to USD 54,270.58 million by 2033, with a projected compound annual growth rate (CAGR) of 6.1% during the forecast period from 2025 to 2033.
The US Farmed Whiteleg Shrimps Market is experiencing significant growth due to rising consumer demand for high-protein seafood and advancements in sustainable aquaculture practices, with production expanding in key coastal and inland farming areas.
The farmed whiteleg shrimps market has seen significant growth in recent years, driven by advancements in aquaculture techniques and a rising global demand for shrimp products. The market is categorized into different types, such as seawater aquaculture and freshwater aquaculture, and includes applications in the food, pharmaceutical, and cosmetics industries. Seawater aquaculture continues to dominate, accounting for over 75% of the total market share, while freshwater aquaculture is gaining traction with a growth rate of approximately 6% annually. This diverse range of uses has contributed to the expansion of the market, with food applications holding more than 80% of the total share. Regional insights point to a strong upward trajectory, with forecasts indicating that the market will continue to grow at a rate of 3-5% annually until 2033, driven by increasing consumer demand and enhanced production capabilities. The pharmaceutical and cosmetics industries are also seeing growing adoption, with both sectors expected to expand by approximately 7% and 5%, respectively.
Farmed Whiteleg Shrimps Market Trends
The global farmed whiteleg shrimps market has seen a robust increase, with notable trends shaping its future growth. As of 2024, the shrimp market is expected to witness a steady rise in demand, particularly driven by the growing global appetite for seafood. Seawater aquaculture, which remains the dominant segment, is expected to contribute over 70% of the market share, while freshwater aquaculture is experiencing a surge in interest. The demand for farmed whiteleg shrimp in the food industry remains the largest, accounting for approximately 80% of the market share, driven by rising consumer preference for high-protein, low-fat seafood options. In addition to the food sector, the pharmaceutical and cosmetics applications are also seeing notable growth, with the pharmaceutical sector expected to grow at a rate of 6% annually due to increasing use of shrimp-based bioactive compounds. Technological advancements in aquaculture, coupled with eco-friendly farming practices, are likely to push market trends toward more sustainable production, benefiting both the environment and the industry. The market is also witnessing the rise of value-added shrimp products, which are increasingly in demand due to their convenience and perceived health benefits.
Farmed Whiteleg Shrimps Market Dynamics
Several key factors drive the farmed whiteleg shrimps market, while also presenting challenges and opportunities for growth. One of the primary drivers is the increasing awareness among consumers regarding the health benefits of shrimp, particularly its high protein content and low-fat profile. This has led to a 10% annual increase in shrimp consumption globally, particularly in markets such as North America and Europe. Moreover, the expansion of aquaculture farms using advanced technology is helping increase production efficiency and meet the growing demand for shrimp. On the other hand, environmental concerns associated with traditional shrimp farming practices, including the impact on marine ecosystems, have raised questions about sustainability. As a result, the industry is shifting towards more sustainable aquaculture practices, which could increase production costs by up to 5%, but ensure long-term growth. Regulatory challenges also pose a significant restraint, as producers must adhere to stringent quality and safety standards for export markets, with compliance costs rising by approximately 8% annually.
DRIVER
"Rising Demand for Pharmaceuticals"
The pharmaceutical sector is a significant driver of the farmed whiteleg shrimps market, especially due to the growing utilization of bioactive compounds derived from shrimp in various treatments. Approximately 8% of the farmed shrimp produced globally is now utilized in the pharmaceutical industry. The increasing use of shrimp-based products for medicinal purposes, such as antioxidants and anti-inflammatory compounds, is enhancing the market's demand. Additionally, research into shrimp-derived ingredients for improving joint health and immunity has led to the formulation of new medicines, further fueling market growth. The pharmaceutical industry is adopting sustainable sourcing practices, which also influences shrimp farming trends.
RESTRAINT
"Environmental Impact of Traditional Farming"
One of the significant restraints in the farmed whiteleg shrimps market is the environmental impact of traditional shrimp farming practices. Conventional methods have led to concerns about the destruction of mangroves and the pollution of water sources due to intensive farming techniques. Around 15% of global shrimp production uses unsustainable methods, causing environmental degradation. This has led to increased regulatory scrutiny and calls for more sustainable practices. As a result, shrimp farmers are facing rising operational costs, with some estimates suggesting that adopting environmentally friendly technologies could increase costs by 5-8%. These constraints could impact the market’s growth potential.
OPPORTUNITY
"Sustainable Aquaculture Techniques"
An emerging opportunity in the farmed whiteleg shrimps market is the adoption of sustainable aquaculture techniques. With growing concerns over environmental sustainability, technologies such as Recirculating Aquaculture Systems (RAS) have become more popular. RAS helps minimize water use and waste, making shrimp farming more eco-friendly. Approximately 25% of global shrimp producers have begun incorporating RAS into their operations, and the number is expected to grow due to increasing consumer demand for sustainably sourced products. Moreover, value-added products such as organic or certified sustainable shrimp have become a growing market segment, particularly in Western countries, where environmental concerns are paramount.
CHALLENGE
"Rising Costs of Shrimp Farming"
One of the critical challenges in the farmed whiteleg shrimps market is the rising cost of shrimp farming. Shrimp feed, labor, and energy costs are increasing steadily, with some farmers reporting up to a 10% annual increase in operational expenses. Furthermore, the cost of adopting new sustainable farming methods, while necessary for long-term viability, requires significant upfront investment. Shrimp farming operations must meet stringent regulatory standards for water quality and traceability, which further adds to costs. As these challenges persist, smaller farms, particularly in developing countries, are struggling to compete with large-scale operations that have more resources to manage these costs.
Segmentation Analysis
The farmed whiteleg shrimps market is segmented by type and application. The two primary types—seawater aquaculture and freshwater aquaculture—are the main drivers of the market. Seawater aquaculture holds a larger share due to the dominance of coastal farming systems, while freshwater aquaculture is gaining popularity, especially in landlocked regions where seawater resources are limited. The applications of farmed whiteleg shrimps span the food, pharmaceutical, and cosmetics industries, with food applications making up the largest share. The increasing trend of incorporating shrimp-based compounds in pharmaceuticals and cosmetics also presents growing opportunities in these sectors.
By Type
- Seawater Aquaculture: Seawater aquaculture remains the dominant segment in the farmed whiteleg shrimps market, accounting for over 75% of global shrimp production. This type of aquaculture thrives in coastal areas, where farmers can utilize the natural seawater environment for shrimp cultivation. In 2024, seawater aquaculture contributed to the vast majority of shrimp farms worldwide, with regions like Southeast Asia, Latin America, and the Middle East seeing a rise in shrimp production in seawater farms. Due to the geographical advantages and established infrastructure in these regions, seawater aquaculture is expected to continue dominating the market. Innovations in sustainable farming practices have also bolstered growth in this segment.
- Freshwater Aquaculture: Freshwater aquaculture, though smaller in comparison to seawater aquaculture, has been gaining ground in recent years. It now accounts for approximately 20% of global farmed shrimp production, and its share is projected to grow steadily. The appeal of freshwater aquaculture lies in its ability to be implemented in inland areas where seawater is not readily available. This type of aquaculture has become particularly popular in regions such as China, the United States, and India, where freshwater resources are abundant. Advancements in freshwater aquaculture techniques, such as water management systems and pond construction, are helping to improve production yields in this segment.
By Application
- Food: The food industry remains the largest application for farmed whiteleg shrimps, accounting for over 80% of the total market share. This dominance is driven by the increasing demand for shrimp as a high-protein, low-fat seafood product. The popularity of shrimp in ready-to-eat meals, frozen foods, and restaurant dishes continues to rise, especially in regions like North America and Europe. In fact, shrimp is one of the most consumed seafood products globally, and its versatility in cooking and processing has cemented its place in the food industry. As health-conscious consumers continue to prioritize lean protein sources, demand for shrimp-based food products is expected to rise.
- Pharmaceutical and Cosmetics: The pharmaceutical and cosmetics sectors have shown growing interest in farmed whiteleg shrimps, although they remain secondary markets compared to the food industry. Shrimp-derived bioactive compounds, such as chitosan and antioxidants, are increasingly used in the production of skincare products, functional foods, and health supplements. In the pharmaceutical industry, shrimp is valued for its immune-boosting properties and is used in the production of medications for joint health, inflammation, and cardiovascular conditions. These sectors are expected to experience steady growth, with pharmaceutical applications likely to grow by approximately 6% annually as shrimp-based compounds gain acceptance in the wellness and cosmetic markets.
Regional Outlook
The global farmed whiteleg shrimps market is witnessing regional growth patterns that reflect varying production capacities, consumer demand, and technological adoption. North America, Europe, Asia-Pacific, and the Middle East & Africa represent key markets for farmed whiteleg shrimp. In particular, regions with extensive coastlines and advanced aquaculture technologies are expected to lead in shrimp production. The growing consumer awareness regarding sustainability and seafood traceability is also influencing regional market dynamics, driving demand for responsibly farmed shrimp in developed regions while boosting production in emerging markets.
North America
North America holds a significant share of the farmed whiteleg shrimps market, accounting for approximately 20% of global production. The United States, in particular, is the largest importer of shrimp globally, with a strong demand for high-quality, sustainably farmed shrimp. In 2024, the market in North America saw an increase in the adoption of sustainable shrimp farming practices, as consumers increasingly demand eco-friendly and traceable seafood. The market in the region is also bolstered by the growth of the restaurant industry and the increasing popularity of shrimp as a protein source in fast-casual dining and ready-to-eat meals.
Europe
Europe is another major market for farmed whiteleg shrimps, with the region contributing approximately 18% to global production. The demand for farmed shrimp in Europe is driven by a growing preference for seafood, particularly in countries like Spain, France, and the United Kingdom. The European market is also seeing a shift towards more sustainable and ethically sourced shrimp, with certifications such as the ASC (Aquaculture Stewardship Council) becoming increasingly important. Additionally, the growing trend of healthy eating and the rising popularity of shrimp in both traditional and innovative European cuisines are contributing to the market's growth.
Asia-Pacific
The Asia-Pacific region is the largest producer and consumer of farmed whiteleg shrimps, accounting for over 50% of global production. Countries like China, Thailand, and India dominate the market, with China being the largest producer of farmed shrimp. This region benefits from an extensive coastline, ideal for shrimp farming, as well as a high demand for shrimp in the domestic market. The rising middle class in Asia is driving increased consumption of shrimp, particularly in processed and convenience food forms. Additionally, the adoption of advanced aquaculture technologies in this region is improving production yields, making Asia-Pacific a key player in the global market.
Middle East & Africa
The Middle East & Africa region, though smaller in comparison to other regions, is gradually expanding its presence in the farmed whiteleg shrimps market. The region accounts for about 5% of global shrimp production, with countries like Saudi Arabia and Egypt seeing increased investments in aquaculture farms. The Middle East, in particular, is focusing on sustainable shrimp farming practices to meet the growing demand for seafood in both domestic and export markets. Additionally, the rising demand for shrimp in the foodservice and retail sectors is contributing to the region's growth, with production increasing by around 6% annually.
LIST OF KEY COMPANIES PROFILED
- Charoen Pokphand Foods PCL
- Cooke Aquaculture
- Omarsa
- Songa
- Santa Priscila
- Expalsa
- Zhanjiang Guolian Aquatic
- Proexpo
- Quoc Viet
- Avanti Feeds
- Caribbean Shrimp Company
- Ananda Group
Top Companies with Highest Market Share
Charoen Pokphand Foods PCL – This company holds the largest share of the market, accounting for approximately 15% of global farmed whiteleg shrimp production.
Cooke Aquaculture – Cooke Aquaculture is another major player in the farmed whiteleg shrimps market, capturing around 12% of the market share.
Investment Analysis and Opportunities
Investment in the farmed whiteleg shrimps market presents strong growth potential due to the increasing global demand for shrimp products, driven by consumer preferences for high-protein, low-fat seafood options. As of 2024, the global shrimp production industry has attracted significant investments from both private and public sectors, particularly focused on improving farming technologies, such as Recirculating Aquaculture Systems (RAS), which help reduce environmental impact and improve sustainability in shrimp farming. Countries in Southeast Asia, Latin America, and North America have seen the largest inflows of investments, as these regions are the primary shrimp producers.
In addition, there is increasing capital directed towards shrimp breeding and genetics research to improve shrimp health, growth rates, and disease resistance. These investments are expected to significantly enhance production capabilities. Furthermore, the growing demand for sustainably farmed shrimp and the rise in eco-conscious consumer behavior presents an opportunity for companies to secure funding for more environmentally friendly practices, such as reducing water usage and adopting carbon-neutral technologies. The market's long-term investment potential is also boosted by the pharmaceutical sector’s growing interest in shrimp-based bioactive compounds, with companies investing in R&D to explore new applications for shrimp-derived products in medicine and cosmetics.
New Product Development
The farmed whiteleg shrimps market is witnessing continuous new product development as producers focus on meeting evolving consumer preferences and market demands. A key area of development is the creation of sustainable and organic shrimp products. Several leading shrimp producers are now offering certified organic shrimp, ensuring that the shrimp are farmed with eco-friendly practices and minimal use of chemicals. This product segment is expected to grow as consumers become more conscious of the environmental and health impacts of their food choices.
Additionally, the trend towards convenience and processed shrimp products has led to innovations such as ready-to-eat shrimp meals, frozen shrimp snack products, and shrimp-based protein supplements. Companies are also exploring the development of shrimp-based functional foods and nutraceuticals, tapping into the health and wellness market. In the cosmetic sector, there has been an increased focus on shrimp-derived collagen and chitosan for use in skincare products, as these ingredients are known for their anti-aging and moisturizing properties. These new product innovations are designed to address both the sustainability concerns of modern consumers and the growing demand for healthy, nutritious, and functional food products.
Recent Developments by Manufacturers
Charoen Pokphand Foods PCL announced in 2023 that it had launched a new range of sustainably farmed shrimp products, with a focus on reducing environmental impact through advanced water treatment technologies. This product line includes shrimp certified by eco-labeling standards.
Cooke Aquaculture expanded its operations in Latin America in 2023, opening a new shrimp farming facility in Ecuador, with a focus on increasing production capacity and improving the sustainability of its farming practices.
Omarsa introduced an innovative shrimp feed formula in 2023 that reduces feed waste and improves shrimp growth rates, helping shrimp farmers reduce costs and increase yield.
Zhanjiang Guolian Aquatic launched a new shrimp breeding program in 2024, aiming to develop disease-resistant shrimp varieties to combat the ongoing challenges of shrimp health in aquaculture.
Proexpo partnered with a leading biotech firm in 2024 to explore the use of shrimp-based compounds in the pharmaceutical sector, particularly focusing on the use of shrimp-derived chitosan in health supplements for joint health.
Report Coverage
This report on the farmed whiteleg shrimps market offers a comprehensive analysis of market trends, growth drivers, and industry challenges. It examines key factors such as the increasing demand for shrimp in food, pharmaceuticals, and cosmetics, as well as regional market insights and forecasts for 2033. The report provides a deep dive into market segmentation, with separate analysis of the seawater and freshwater aquaculture segments. It also highlights emerging opportunities for sustainable shrimp farming practices and new product development, including innovations in shrimp feed and shrimp-based bioactive compounds. Key players in the market, such as Charoen Pokphand Foods PCL, Cooke Aquaculture, and others, are profiled to provide insights into their strategies for growth. The report also offers a detailed look at regional dynamics, with specific focus on North America, Europe, Asia-Pacific, and the Middle East & Africa, providing a global perspective on the market’s trajectory. This report is a valuable resource for stakeholders looking to understand market opportunities, threats, and growth areas in the farmed whiteleg shrimps industry.
Report Coverage | Report Details |
---|---|
Top Companies Mentioned | Charoen Pokphand Foods PCL, Cooke Aquaculture, Omarsa, Songa, Santa Priscila, Expalsa, Zhanjiang Guolian Aquatic, Proexpo, Quoc Viet, Avanti Feeds, Carribbean Shrimp Company, Ananda Group |
By Applications Covered | Food, Pharmaceutical and Cosmetics |
By Type Covered | Seawater Aquaculture, Freshwater Aquaculture |
No. of Pages Covered | 99 |
Forecast Period Covered | 2025 to 2033 |
Growth Rate Covered | CAGR of 6.1% during the forecast period |
Value Projection Covered | USD 54270.58 Million by 2033 |
Historical Data Available for | 2020 to 2023 |
Region Covered | North America, Europe, Asia-Pacific, South America, Middle East, Africa |
Countries Covered | U.S. ,Canada, Germany,U.K.,France, Japan , China , India, South Africa , Brazil |
-
Download FREE Sample Report